Cell therapy weekly: initiative to advance stem cell research and treatments makes California state ballot

This week: Green Cross LabCell (Yongin, South Korea) has announced its procurement of a patent from the Japanese Patent Office for a natural killer (NK) cell culture method, Cynata Therapeutics (Melbourne, Australia) has announced its receipt of ethical approval from the University of Sydney Human Research Ethics Committee (Sydney, Australia) for a Phase III clinical trial of a mesenchymal stem cell (MSC) product for osteoarthritis and Orca Bio (CA, USA) has announced US$192 million in Series D financing. The news highlights: Initiative to advance stem cell research and treatments makes California state ballot Japanese patent procured to allow continued commercialization...